The AGT M235T polymorphism may contribute to IHD risk by increasing angiotensinogen levels, enhancing the renin-angiotensin-aldosterone system (RAAS), and promoting endothelial dysfunction and vascular remodeling (31). Here, AGT is linked to endothelial dysfunction.